You’re invited to an online meeting: Utility of 18F-NaF PET/CT Imaging in Prostate Cancer Presenter: Robert Bridwell, M.D., M.B.A., Medical Advisor to IBA Molecular Dr. Robert Bridwell, medical advisor to IBA Molecular North America, and co-founder of PETLinQ, is a board-certified physician in both Internal Medicine and Nuclear Medicine. He has extensive knowledge and experience in continuous quality improvement programs for PET and PET/CT imaging, utilizing physician empowerment training, protocol development assistance, and quality assurance guidelines. In the last five years, Dr. Bridwell has been invited to make numerous presentations, which have included more than 1200 hours of CME credit delivered to more than 350 institutions, 100 professional society meetings and more than 150 radiology groups throughout the United States, Canada and Europe. Who should attend? Referring Physicians, PET Interpreters, Technologists, Marketers In this session, Dr. Bridwell will: Compare the relative sensitivity, specificity and accuracy of 18F-NaF PET/CT and TC99 MDP planar bone imaging in the detection of skeletal metastases Discuss specific clinical settings for Prostate Cancer where accurate identification of bone metastases may impact the management of patients Detail current literature and guidelines regarding the use of 18F-NaF PET/CT for this indication Review case studies to illustrate where 18F-NaF PET/CT can deliver important diagnostic information to the clinician Open the session for your questions regarding appropriate and effective approaches regarding this topic THIS ACTIVITY IS APPROVED FOR CREDIT BY THE ASRT To receive CE credit you must register individually, attend the entire session and complete a post-webinar survey. Instructions regarding receiving CEH (1.0) will be provided at the conclusion of the session. USE APPROPRIATE NCED OF ADVA G IMAGIN This webinar is part of our Appropriate Use Initiative, supporting the evidence-based utilization of advanced imaging to improve patient care and outcomes. The stamp identifies each of the educational elements available in this program. Go to ibamolecular. com/appropriateuse for more information. Register Today! Utility of 18F-NaF PET/CT Imaging in Prostate Cancer Event Date: Tuesday, March 25, 2014 Event Time: 3:00 pm, EDT or go to https://www4.gotomeeting.com/register/699491127 Upon registration approval, you will receive a confirmation email with the information to join the webinar and teleconference. Provided exclusively for IBA Molecular customers. This webinar is part of IBA Molecular’s Appropriate Use Initiative. For a full 2014 schedule, please visit http://www.ibamolecular.com/educational-learning-series or ask your IBA Molecular clinical account executive. IBA Molecular North America, Inc. 21000 Atlantic Blvd., Suite 730 | Dulles, VA 20166 | Toll Free: 1 877 334 3673 | Tel.: + 1 703 787 7900 | Fax: + 1 571 434 0330 | www.ibamolecular.com March 2014 | ELS Webinar Invitation © IBA Molecular North America, Inc. 2014 / All Rights Reserved.
© Copyright 2021 ExpyDoc